Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Goodwill & Intangibles (2017 - 2025)

Ultragenyx Pharmaceutical (RARE) has disclosed Goodwill & Intangibles for 9 consecutive years, with $241.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 8.56% to $241.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $241.0 million, a 8.56% increase, with the full-year FY2025 number at $241.0 million, up 8.56% from a year prior.
  • Goodwill & Intangibles was $241.0 million for Q4 2025 at Ultragenyx Pharmaceutical, up from $217.3 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $241.0 million in Q4 2025 to a low of $175.2 million in Q4 2021.
  • A 5-year average of $204.4 million and a median of $206.3 million in 2022 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: increased 18.83% in 2022, then fell 0.54% in 2023.
  • Ultragenyx Pharmaceutical's Goodwill & Intangibles stood at $175.2 million in 2021, then grew by 18.83% to $208.2 million in 2022, then rose by 1.2% to $210.7 million in 2023, then grew by 5.37% to $222.0 million in 2024, then rose by 8.56% to $241.0 million in 2025.
  • Per Business Quant, the three most recent readings for RARE's Goodwill & Intangibles are $241.0 million (Q4 2025), $217.3 million (Q3 2025), and $219.1 million (Q2 2025).